Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study
Cost Sharing, Acute Coronary Syndrome
18 Years - 130 Years
Endpoint Classification: Efficacy
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Verified 01 Sept 2019 by AstraZeneca
Duke Clinical Research Institute
No locations available
|Experimental: Copayment Intervention Arm|
Sites in the intervention arm will provide patients with a study voucher card to offset any patient copayments or medication card for the filling of any prescriptions of clopidogrel or ticagrelor.
Other: Study voucher card
Study voucher card to offset any patient copayments or medication costs for the filling of any prescriptions of clopidogrel or ticagrelor
|No Intervention: Usual Care Arm|
For hospitals randomized to the control arm, all patients receive usual care and no study intervention is performed.